Hiles - Treating Perinatal Opioid Use and Neonatal Opioid Withdrawal
CE Information
1.0 CE credit (1.0 pharmacology)Completion Time
1 hourAvailable Until
May 31, 2027
Navigate
Overview
Specialties
Family, Pediatric, Psychiatric / Mental Health, and Women's HealthSubspecialties
Other, Pain Management, and Primary CareClinical Topics
CDC, Mental Health, Neonatal, Pain, Pharmacology, Primary Care, Treatment, and Women's HealthReview opioid use disorder and some treatment options during the perinatal and postpartum period, as well as the impact on the newborn.
Learning Objectives
- Demonstrate the importance of the treatment of opioid use disorder in the perinatal period and the impact on the newborn after delivery
- Identify medications that impact the perinatal patient during pregnancy and in the postpartum period.
- Recognize the impact of perinatal opioid use on the newborn and describe the treatments and medications available to treat neonatal opioid withdrawal.
Speakers
Marianne Hiles is a highly experienced Clinical Nurse Specialist (CNS) with over 30 years of expertise in Maternal-Child Health. As the Clinical Nurse Specialist for the Family Center at Frederick Health Hospital, she provides advanced nursing care and leadership in postpartum, newborn nursery, and antepartum settings. Marianne earned her Master of Science in Nursing (MSN) from Indiana University School of Nursing in 2011, specializing as an Adult Health CNS. She is a board-certified Adult Health Clinical Nurse Specialist and holds additional certifications in low-risk neonatal care, electronic fetal monitoring, and is recognized as a Fellow of the Clinical Nurse Specialist Institute (FCNS). With a deep commitment to improving perinatal care, Marianne has dedicated over 20 years to working with patients affected by opioid use disorder and their newborns. Her passion for advancing care in this field led her to pursue an advanced practice nursing degree, allowing her to drive impactful changes in the management and outcomes of this vulnerable population. Through her expertise, advocacy, and leadership, Marianne continues to elevate the standard of care for maternal and neonatal patients.
CE Information
This activity offers 1.0 CE credit (1.0 pharmacology) to attendees.
Accredited by AANP.
This presentation meets Maryland’s 2018 requirement for applicants registering for new or renewing CDS registration (Safe Prescribing of Opioids) and the Consolidated Appropriations Act of 2023 requirement of an eight-hour training requirement for all DEA-registered practitioners on the treatment and management of patients with opioid or other substance use disorders.
This activity is approved for 1.0 contact hour(s) of continuing education (which includes 1.0 hour(s) of pharmacology) by the American Association of Nurse Practitioners®. Activity ID# 25047155. This activity was planned in accordance with AANP Accreditation Standards and Policies.”
Disclosures
There are no disclosures.
Activity Content
Registration to this activity includes access to the following supporting materials.
- Perinatal Opioid Use (Size: 1.05 MB)
Duration: about 1 hour | Quality: HD
1 question
Access your certificate